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Scaffolding proteins in the development and maintenance of the epidermal
permeability barrier
Melissa Crawford and Lina Dagnino
Department of Physiology and Pharmacology, Children’s Health Research Institute and Lawson Health Research Institute, The University of
Western Ontario, London, Ontario, Canada

ABSTRACT

ARTICLE HISTORY

The skin of mammals and other terrestrial vertebrates protects the organism against the external
environment, preventing heat, water and electrolyte loss, as well as entry of chemicals and
pathogens. Impairments in the epidermal permeability barrier function are associated with the
genesis and/or progression of a variety of pathological conditions, including genetic inﬂammatory
diseases, microbial and viral infections, and photodamage induced by UV radiation.
In mammals, the outside-in epidermal permeability barrier is provided by the joint action of the
outermost corniﬁed layer, together with assembled tight junctions in granular keratinocytes found
in the layers underneath. Tight junctions serve as both outside-in and inside-out barriers, and
impede paracellular movements of ions, water, macromolecules and microorganisms. At the
molecular level, tight junctions consist of integral membrane proteins that form an extracellular seal
between adjacent cells, and associate with cytoplasmic scaffold proteins that serve as links with the
actin cytoskeleton. In this review, we address the roles that scaffold proteins play speciﬁcally in the
establishment and maintenance of the epidermal permeability barrier, and how various pathologies
alter or impair their functions.
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Introduction
The complex architecture of the epidermis gives rise to
the multifaceted nature of its barrier functions. The
barrier characteristics of the epidermis can vary,
depending on age, body site, species and health status.
In mammals, the outside-in epidermal permeability
barrier is provided at 2 levels: the ﬁrst is the outermost
corniﬁed layer, whereas the second is formed through
the assembly of tight junctions in granular keratinocytes found in the layers underneath the corneocytes.
Tight junctions are also found in the epidermis of
amphibians and reptiles, underlining the importance
of this inner epidermal barrier across vertebrates.
A large body of work has focused on deciphering the
molecular basis for the formation of these diverse barriers and how their disruption can lead to cutaneous
diseases. In this review, we summarize and discuss the
physiologic roles of scaffold proteins in development
and maintenance of the epidermal permeability barrier, and the pathological impact of their alterations
on the epidermis.
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As the outermost organ, the skin constitutes a
watertight barrier against the external environment,
allowing humans and other organisms to survive in
terrestrial conditions. The skin shields all internal tissues against external insults, including chemicals,
pathogens and physical agents. Structurally, the skin is
composed of an inner dermis and an outer epidermis.
The epidermis is a stratiﬁed squamous epithelium,
which endows the skin with its extraordinary
permeability barrier properties.1,2
The epidermis is formed by one basal and several
suprabasal layers of keratinocytes. The latter are the
main cellular constituents of this tissue. Each epidermal layer contains keratinocytes at a particular stage
of differentiation.3-5 The basal layer contacts extracellular matrix proteins on the basement membrane that
separates the dermis from the epidermis, and is composed of undifferentiated keratinocytes, including
stem cells and their transit-amplifying progeny. Basal
keratinocytes have high proliferative capacity and are
key for epidermal maintenance and regeneration after
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injury.6,7 Expression of proliferation-inducing transcription factors, as well as keratins 5 and 14 are characteristic of these cells.4,8-11 Differentiation of basal
keratinocytes gives rise to mature cells that form the
suprabasal layers. Differentiated keratinocytes do not
proliferate, but rather form strong intercellular adhesions (adherens and tight junctions, as well as desmosomes). A subset of differentiated keratinocytes is
responsible for the barrier functions of the
epidermis.12-14
Suprabasal keratinocytes exist in various differentiation states, and exhibit distinct molecular and functional characteristics, depending on their location
within the epidermis. Several spinous cell layers are
found immediately above the basal keratinocytes.15
Common to all spinous keratinocytes are the presence
of abundant desmosomes and the expression of keratins 1 and 10, which are early differentiation markers
that replace keratins 5 and 14. The robust cytokeratin
network in spinous cells allows the strengthening of
intercellular junctions, key for the mechanical resistance of the epidermis.16 Spinous keratinocytes however, also exhibit a degree of heterogeneity.
Speciﬁcally, at later stages of differentiation, activation
of a gene cluster termed the “epidermal differentiation
complex” (EDC) in the outermost spinous keratinocytes results in the expression of the intermediate
differentiation markers involucrin and loricrin.17
Overlaying the spinous cells are 3–5 granular cell
layers, characterized by the presence of intracellular
lamellar bodies and keratohyalin granules. Characteristic markers of granular keratinocytes are loricrin and
ﬁlaggrin. Functionally, the stratum granulosum contains tight junctions, which form the basis for an
important component of the permeability barrier
properties in the epidermis. In addition, caspase-14,
which is expressed in all suprabasal keratinocytes, is
activated in granular cells, setting in motion corniﬁcation processes, the ﬁnal steps of keratinocyte differentiation.18,19 During this stage, the nucleus and all cell
organelles are degraded through poorly understood
mechanisms, ultimately giving rise to the transition
from the granular to the corniﬁed layers.20
The corniﬁed envelope consists of 15–20 layers of
dead, extensively cross-linked corniﬁed keratinocytes
(also termed corneocytes). The biophysical characteristics of the stratum corneum allow it to function as
an efﬁcient barrier against pathogens and chemicals,
simultaneously providing the epidermis with its

mechanical strength.21 The formation of the corniﬁed
layer involves cross-linking of proteins at the cell
periphery and loss of intracellular organelles and
DNA. Concomitantly, strong and stable links form
between corneocytes to generate a dense mesh-like
structure.20 Those corneocytes closest to the granular
layer are arranged in a tight pattern, whereas those in
the outermost layers are less tightly linked and
undergo desquamation through processes that involve
proteolysis by kallikreins and other enzymes.20 In
addition to forming a sealed envelope built with crosslinked proteins, corneocytes are also embedded in a
lipid matrix composed of sebum secreted by the sebaceous glands, together with lipids extruded by the keratinocyte lamellar bodies. These lipid components
endow the corniﬁed layer with its water-repellent
properties and are strongly connected via corneodesmosomes, ensuring the physical strength of the
corniﬁed envelope.20,21
The lipids in the corniﬁed layer play key roles in
preventing excessive water loss and maintaining
appropriate hydration of the epidermis.22 Together
with the size of the corneocytes and their intercellular
spaces, corniﬁed envelope lipids are also key determinants of the types of substances that can be absorbed
from the skin surface through diffusion.23 These substances are typically non-polar compounds with
molecular weight below 500 Da.24

The tight junction barrier in the epidermis
Tight junctions constitute cell-cell seals that limit paracellular movements of molecules across epithelia. In
renal, intestinal and other simple epithelia, tight junctions between adjacent cells are found in the uppermost
regions of the lateral aspect of the cells, separating the
basal and apical cell surfaces.25 At the molecular level,
the tight junction skeleton consists of integral membrane
proteins that form a link between adjacent cells and control paracellular solute movements. In the epidermis, the
tight junction transmembrane proteins claudins, tight
junction-associated marvel protein (TAMP) and junctional adhesion molecule (JAM) are expressed.15 Associated with the transmembrane junctional proteins are
cytoplasmic scaffold proteins that include Zonula occludens (ZO) and cingulin, which also function as hubs for
a variety of factors involved in signaling and transcriptional regulation.13,26-29 The ZO family is composed of 3
members (ZO-1, ZO-2 and ZO-3) with ubiquitous tissue
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distribution, and which provide the structural basis for
the assembly of multiprotein complexes at the plasma
membrane.30 ZO proteins, which are exclusively present
in metazoans, additionally associate with each other to
form homo- or heterodimers that regulate tight
junctions and various other signaling modules.
Core transmembrane components of the tight
junctions
Claudins
Claudins are major structural components of tight
junctions. They associate as homo- or heteroligomers,
forming paracellular barriers and pores that determine
their speciﬁc properties and their regulation of
epidermal inside-out permeability toward small
molecules.13,31,32 Claudins interact through their cytoplasmic PDZ domains with various scaffold proteins,
and these interactions appear to be obligatory for the
assembly of the junction complex.33 Although a functional tight junction barrier is restricted to a subset of
granular layers in the epidermis,13 different claudins
are expressed throughout this tissue.15 In particular,
claudins 1, 4, 6, 7, 10, 11, 12, 17 and 18 are found in
the stratum granulosum.13,26,34-36 Alterations in claudin protein levels or deletion of the PDZ-containing
cytoplasmic domain in claudin-6 induce pronounced
epidermal permeability barrier defects.12,34,37
Occludin
Occludin is a 65-kDa 4-transmembrane domain protein
that associates with tight junctions and is present in the
stratum granulosum of the epidermis.28,38 Occludin also
binds to scaffold proteins present in tight juctions,
including ZO-1.39 Proteolytic cleavage of the occludin
extracellular domain mediated by matrix metalloproteinases increases paracellular permeability.40 Signiﬁcantly,
targeted inactivation of the Ocln gene in mice gives rise
to morphologically intact tight junctions, but chronic
inﬂammation potentially due to poor barrier function, in
various internal epithelia,41 suggesting the possibility
that occludin may additionally modulate epidermal tight
junctions in a manner still poorly understood.
Scaffolding proteins of the tight junctions
Zonula occludens (ZO) proteins
Some of the most prominent and best characterized
scaffold proteins on the cytoplasmic aspect of the epithelial tight junction are the ZO proteins, 3 forms of
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which are known in mammals (ZO-1, ZO-2, ZO3).25,42 These members of the membrane-associated
guanylate kinase (MAGUK) family are characterized
by the presence of 3 N-terminal PDZ domains, a central Src homology 3 (SH3) region, and a catalytically
inactive C-terminal domain with homology to guanylate kinase.43-45 ZO proteins are targeted to the plasma
membrane and localize immediately underneath the
tight junctions, through binding to occludin and claudins, as well as to phosphoinositides in the plasma
membrane.25,46 ZO-1, the 225-kDa ﬁrst discovered
member, has both nuclear localization and nuclear
export signals, and is found in the nucleus during
remodelling of intercellular contacts.47 ZO-1 is
expressed in the granular keratinocyte layers, and its
abundance in differentiating keratinocytes is positively
regulated by p38d mitogen-activated protein kinase.48
Both ZO-1 and ZO-2 have also been detected in the
upper spinous layers, where they may fulﬁll additional
functions independent of tight junctions.15
Cingulin
Cingulin is a 140-kDa peripheral membrane protein
composed of coiled-coil domains, which binds to ZO1 at tight junction plaques.49 Although targeted gene
inactivation or silencing of cingulin expression does
not disrupt tight junction formation in simple epithelia, this protein plays both structural and signaling
roles.50 Cingulin exhibits actin-bundling activity
in vitro, and has been implicated in anchoring of both
actin ﬁlaments and a planar apical network of microtubules to the tight junctions. The anchoring and
organization of microtubules mediated by cingulin
requires phosphorylation of this protein at tight junction sites by adenosine monophosphate protein kinase
(AMPK), further illustrating the importance that
cingulin has as a signaling hub.51,52

Assembly of the tight junctions in the epidermis
Epithelial cells both in simple and stratiﬁed epithelia
establish apical-basal polarity through the assembly of
tight junctions. In culture, undifferentiated epidermal
keratinocytes do not form cell-cell adhesions, as the
culture conditions do not provide sufﬁciently high
extracellular Ca2C concentrations to allow establishment of intercellular junctions.53 Upon increasing the
extracellular Ca2C concentration, keratinocytes begin
a process of differentiation, mimicking suprabasal
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cells. They form a sealed epithelial sheet characterized
by the formation of desmosomes, adherens and tight
junctions.54 Immediately following Ca2C stimulation,
cultured keratinocytes extend numerous F-actin-rich
ﬁlopodia, which slide along those formed by adjacent
cells. E-cadherin complexes also containing catenins
cluster at the tips of these ﬁlopodia, which become
sites where prominent actin ﬁbers also polymerize and
extend toward the cortical F-actin cytoskeleton.54 ZO1 is present in these structures, indicating that during
the early stages of cell-cell junction formation, components of both adherens (E-cadherin, catenins) and
tight junctions (ZO-1) are delivered from intracellular
stores to sites of cell-cell contact.55 Signiﬁcantly, in
cultured keratinocytes and other vertebrate cells, the
formation of early cadherin-containing adhesions is
an essential prerequisite for the subsequent assembly
and maintenance of tight junctions.56
In epidermal tissues, claudins 1, 4, 7, 11, 12 and 18,
occludin, ZO-1, ZO-2, cingulin and Multi-PDZ
Domain Protein 1 (MUPP-1) localize to cell-cell borders in the stratum granulosum, and are associated
with the functional tight junction barrier. Notably,
some tight junction proteins also localize to all epidermal layers (e.g. claudins 1, 7, and 12, Junctional Adhesion Molecule (JAM)-A, and MUPP1), or to the
spinous keratinocytes (e.g., ZO-1, ZO-2, claudins 4, 6,
18).26-28,35,57-62 Similar to observations in cultured keratinocytes, disruption of cadherin-containing adherens junctions in vivo results in impairment in tight
junction formation. Targeted inactivation of Cdh1 in
mice, which encodes E-cadherin, results in extensive
transepidermal water loss and loss of functional tight
junctions in the stratum granulosum.63 In these mice,
paracellular diffusion of ions was also increased due to
enhanced tight junction permeability. These defects
were associated with altered distribution of ZO-1 and
claudin-1 at the membrane of granular keratinocytes.
Thus, although the absence of E-cadherin in the epidermis does not completely obliterate tight junctions,
it prevents assembly of key constituents and proper
barrier function. A more pronounced phenotype is
observed in mouse epidermis lacking both E- and Pcadherin, in which localization to cell-cell borders of
occludin, claudin-1 and ZO-1 is perturbed, impairing
tight junction assembly in the granular layer.64 Thus,
cadherins play critical roles in the assembly and/or
stability of epidermal tight junctions, both in culture
and in vivo.

Nature of paracellular transport through tight
junctions: Inside-out and outside-in barrier
properties
Tight junctions are major determinants of paracellular
barrier function in all epithelial cells. Two types of
permeability barriers regulated by tight junctions have
been deﬁned in terms of the types of substances whose
movement they regulate.65 The ﬁrst one has been
termed the “pore pathway," and is characterized by
high capacity, and allows permeability of small
uncharged solutes and speciﬁc ions. Pore pathway
characteristics are mainly determined by the particular
claudin forms found at the tight junction, and may
also be regulated by protein-protein interactions. The
second type of permeability barrier is termed the “leak
pathway." It has low capacity, is permeable to larger
macromolecules, and does not exhibit selectivity
toward ions.65 ZO-1, occludin and the actin cytoskeleton play key roles in the modulation of the leak
pathway.65
The organization of tight junctions in the multilayered epidermis is not identical to that described in
simple epithelia. For example, the functions associated
with tight junction assembly in the epidermis have
been described in terms of inside-out and outside-in
permeability barriers, depending, respectively, on
whether a substance leaves the skin toward the external environment, or enters the skin from the outside.15
In addition, epidermal tight junctions do not necessarily modulate permeability to cations, anions, small
molecules, tracers, antigens and water in identical
manners.
The inside-out permeability barrier in the epidermis is important to prevent ﬂuid and ion loss from the
organism toward the exterior. Loss of tight junctions
causes increased transepidermal water loss in vivo,
which, depending on its severity and the presence of
other epidermal abnormalities, may be lethal.13 Lanthanum has been used as a tracer to demonstrate an
inside-out barrier toward ions in the stratum granulosum in situ,66 and the existence of a tight junctionassociated barrier toward the small 557-Da solute
sulfo-NHS-LC-biotin in the stratum granulosum in
vivo has also been demonstrated.13 In contrast, the
demonstration of outside-in permeability barrier characteristics of the epidermal tight junctions has been
more challenging. This is due to the existence of the
stratum corneum barrier, which impedes passage of
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many solutes, and experimental manipulations that
remove the stratum corneum barrier can also damage
the underlying tight junctions.67
The pore and leak pathways associated with tight
junctions have been investigated at the cellular level in
keratinocyte monolayers induced to differentiate and
to assemble strong cell-cell junctions by culture in
growth medium supplemented with 1.0–1.8 mM
Ca2C.68,69 Transepithelial resistance (TER) has been
used as a measure of the barrier function toward ions
provided by tight junctions in submerged human and
mouse keratinocyte monolayers.68,69 Upon induction
of differentiation by Ca2C, pronounced increases in
TER are observed in conﬂuent keratinocyte monolayers, which provide a measure of tight junction
assembly and functionality.68,69 Further, the use of 2path impedance spectroscopy has demonstrated that
the increases in TER associated with decreased ion
permeability in Ca2C-treated human keratinocyte
monolayers are primarily due to decreased paracellular permeability, with only very minor contributions
from changes in tight junction-independent transcellular permeability.70
The paracellular ion permeability barrier in human
keratinocyte monolayers treated with Ca2C is selective:
anions (e.g., Cl¡) are less permeable than divalent cations (e.g., Ca2C), which, in turn, are less permeable
than monovalent cations (e.g., NaC).70 In culture, the
permeability barrier to ions reaches maximum levels
only after 48 h of culture in medium with high Ca2C,70
indicating that this interval is necessary for the full
maturation of tight junctions in cultured keratinocytes. Similarly, paracellular transepithelial water
ﬂuxes also decrease with the formation of tight junctions in human keratinocyte monolayers.70
Examination of the leak pathway in cultured keratinocyte monolayers has also demonstrated the existence of a permeability barrier toward larger
molecules, such as ﬂuorescein (332 Da), and ﬂuorescein-labeled dextrans of small and medium molecular
weights (3–40 kDa).71-74 Under these conditions, the
barrier toward these larger solutes is observed at earlier times after the induction of tight junction assembly, compared with the formation of barriers toward
ions.70 Signiﬁcantly, silencing of either claudin 1, claudin 4, occludin or ZO-1 in Ca2C-treated human keratinocyte monolayers reduced paracellular TER, and
abrogated the permeability barrier to ions, small- and
intermediate-size macromolecules, further conﬁrming
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the involvement of tight junctions in these properties
of epidermal cells.70

Scaffold proteins involved regulation of tight
junctions in the epidermis
Polarity proteins

In addition to ZO scaffold proteins, which are found
at tight junction plaques, other adaptor proteins modulate tight junction assembly and/or function. Tight
junctions are key determinants of cell polarity in simple epithelia.25 Because of its stratiﬁed architecture,
the epidermis also exhibits cell polarity, although the
manner in which it is organized is not identical to that
in simple epithelia. The apical-basal axis of epithelial
cells is also characterized by the expression of polarity
proteins such as the PAR (Partition-defective),
Crumbs and Scribble protein complexes.75
The best-studied polarity proteins are the PAR proteins, which are necessary for the establishment of cell
polarity and for the proper formation of tight junctions.76,77 The par genes were ﬁrst identiﬁed in Caenorhabditis elegans as regulators of zygote anteriorposterior polarity.78 Since their discovery, polarity
proteins have been shown to play important roles in
other organisms, such as in Xenopus, where they regulate gastrulation,79 and in mammals, where they are
involved in epithelial polarization,80,81 as well as in
neuronal dendritic spine morphogenesis.82 The mammalian homologs Par3 and Par6, together with atypical protein kinase C(aPKC), form the “polarity
complex." Par3 and Par6 contain PDZ domains, which
enable them to bind to each other and act as scaffolds
for other proteins. Par6 functions as an adaptor protein connecting Par3 with aPKC and the small GTPase
Cdc42, when activated and bound to GTP (Cdc42GTP).83 These interactions are important for tight
junction formation.83 Par6 inhibits aPKC kinase activity. This inhibition is relieved through interaction of
Par6 with Cdc42-GTP, which induces a conformational change in Par6, no longer allowing it to inhibit
aPKC. In this manner, the latter can then phosphorylate its substrates.68 Par3/Par6/aPKC proteins are not
always found together in a complex. One of the substrates of aPKC is Par3, and phosphorylation of Par3
results in its partial dissociation from the complex.
Another polarity protein known as Crumbs
completely displaces Par3, resulting in localization of
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Par6 and aPKC at the apical membrane and of Par3 at
tight junctions.84
Par proteins, along with aPKC, are regulators of
epithelial polarization and tight junction assembly,
maturation and function. In Madin-Darby Canine
Kidney (MDCK) epithelial cells, Par3, in complex
with ASIP (atypical PKC isotype speciﬁc interacting
protein), is involved in the regulation of tight junction
formation. The role of Par3 in this context is not limited to functioning as a structural protein.85 RNAimediated silencing of Par3 in mammalian epithelial
cells signiﬁcantly delays the formation of tight junctions by disrupting the localization of other polarity
markers such as aPKC.86 Signiﬁcantly, Par3 silencing
also resulted in a delay in the formation of adherens
junctions.86
In the epidermis, polarity is mainly established
along the basal-to-apical axis, but the mechanisms
that regulate polarized protein distribution throughout the different epidermal layers are not well understood. Par3 is present in cultured primary
keratinocytes and in all living epidermal layers.87 In
keratinocyte monolayers, Par3 associates with Tiam1,
and this association is necessary for assembly and barrier function of tight junctions.72 In this system,
Tiam1 functions upstream from the polarity complex,
mediating activation of the small GTPase Rac1, which
in turn activates the polarity complex.72 Whether this
mechanism is operative in the assembly of tight junctions in granular keratinocytes in vivo has yet to be
determined. Par3 co-localizes with ZO-1 in stratum
granulosum keratinocytes, and is required for proper
aPKC localization to tight junctions and signaling.87
Genetic inactivation of Par3 in newborn mouse epidermis results in pronounced perturbations in the
tight junction permeability barrier to small solutes
and increased transepidermal water loss, as well as
reduced ZO-1, claudin-1 and occludin levels and their
abnormal localization in granular keratinocytes.80 In
spite of these abnormalities, these mice survived to
adulthood, at which time tight junction function and
protein expression had normalized, indicating the
possibility of activation of compensatory mechanisms.
In newborn mouse epidermis, aPKCi/λ has been
found co-localized at cell-cell borders with Par3 and
Par6 speciﬁcally in granular keratinocytes.68 Further,
in response to Ca2C-induced differentiation in primary keratinocytes, recruitment of ZO-1 and occludin
at cell-cell contacts, tight junction assembly and

barrier function are accelerated in the presence of
exogenously expressed aPKCi/λ. Of note, epidermisrestricted inactivation of the gene that encodes
aPKCi/λ was not reported to result in any changes in
tight junction function that affected viability, although
it caused pronounced defects in hair follicle stem cell
maintenance.88 Thus, the precise role that aPKCi/λ
plays in the assembly, maintenance and function of
epidermal tight junctions in vivo remains to be
elucidated.
Afadin

Afadin is a scaffold protein containing a PDZ domain,
which localizes to cell-cell junctions and also binds Factin.89 In epidermal keratinocytes and other epithelial
cells, afadin interacts with the 4 members of the nectin
transmembrane adhesion protein family, connecting
them with the actin cytoskeleton.89 Afadin is also
required for nectin signaling at tight junctions,
through its interactions with ZO-1.89 Afadin is
involved in functionally linking adherens and tight
junctions, especially during junction assembly and
remodeling, although it appears to be dispensable for
epidermal stratiﬁcation and viability in mice.90
Recently, an additional, unexpected role for afadin in
tight junction assembly that involves its interactions
with the Ephrin receptor EphA2 has been described.91
EphA2 is a transmembrane receptor tyrosine kinase
expressed in a polarized fashion in the upper suprabasal layers of the human epidermis.91 This receptor
fulﬁlls several functions in the epidermis, including
protection against chemically-induced carcinogenesis,92 modulation of keratinocyte adhesion and tight
junction formation.93 Afadin binds to EphA2, and in
the absence of the latter the subcellular distribution of
afadin and occludin changes from mainly junctional
to cytoplasmic.91 These changes are also associated
with defects in the tight junction permeability barrier
to ions and a dextran tracer. Thus, the interactions of
afadin with EphA2 are essential for tight junction
assembly.
Integrin-linked kinase

Integrin-linked kinase (ILK) is a 51-kDa scaffold protein with no catalytic activity, that associates with
integrins and localizes to cell-cell junctions in cultured
differentiated keratinocytes, in a Ca2C-dependent
manner.94,95 In the epidermis, ILK is expressed in all
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living keratinocyte layers, as well as in hair follicles,96
and is important for maintenance of follicular and
interfollicular keratinocyte cell polarity. Epidermisrestricted Ilk gene inactivation during embryogenesis
abrogates the apical distribution of E- and P-cadherin
in developing hair follicles, and alters the cortical actin
cytoskeleton in follicles and in the interfollicular epidermis.97,98 In cultured keratinocytes, Ca2C induction
of differentiation and cell-cell junction formation
involves activation of the G-protein coupled Ca2Csensing receptor (CaSR), which in turn triggers activation of RhoA and delivery of E-cadherin to form adherens junctions.99,100 In vivo, CaSR is also essential for
the establishment of the tight junction barrier in
mice.101 In the absence of ILK, signaling through
CaSR is altered and RhoA activation is impaired in
cultured keratinocytes.102 Under these conditions, Ecadherin, and ZO-1 fail to translocate to the cell membrane, through mechanisms that involve impaired
RhoA activation and endosomal delivery of junction
proteins to the plasma membrane.103 As a result,
adherens and tight junctions fail to form. These alterations are reﬂected in barrier defects in vivo, as ILKdeﬁcient epidermis exhibits altered ZO-1 and claudin1 distribution in granular layers, reduced ZO-1
expression and tight junction formation. These abnormalities are also associated with increased permeability to medium molecular-weight tracers, indicating
impairment of paracellular tight-junction barrier
properties toward macromolecules.102

Disruption of tight junctions and barrier
properties in epidermal diseases
Several human disorders and alterations are associated
with disruption of tight junctions, through mechanisms that target various components of these structures directly or indirectly. These diseases include
hereditary disorders involving genetic mutations,
inﬂammatory processes and responses to pathogens
and environmental insults.
Photoaging and UV radiation

The chronic exposure of the skin to UV radiation and
other environmental insults, together with chronological aging, alters several properties of the skin.104 UV-A
light (λ320–400 nm) is able to penetrate deeper into
the dermis and is associated with changes in dermal
collagen and dermal elasticity.105 In contrast, the
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range of penetration of UV-B radiation (λ290–
315 nm) is largely limited to the epidermis, causing
damage due to the production of reactive oxygen species, macromolecule modiﬁcation and degradation,
and DNA damage.106-108 Few studies have investigated
the consequences on epidermal tight junctions upon
UV irradiation.
In addition to damaging macromolecules, UV radiation also severely disrupts the cutaneous permeability
barrier. UV-B irradiation of human skin xenografts in
immunodeﬁcient mice results in increased transepidermal water loss, which remains at a maximum 24–
72 h after irradiation, and returns to normal levels by
144 h.69 These alterations were reportedly accompanied by loss of inside-out barrier capacity in the upper
stratum granulosum, which was also re-established
144 h post-irradiation. Similar disruptions in the tight
junction barrier were observed in UV-irradiated
human skin organotypic cultures 69 and in a hairless
mouse model.109 At the cellular level, these alterations
were accompanied by disassembly of tight junctions,
through mechanisms that involved abnormal Rac1
activation of the polarity complex, speciﬁcally atypical
PKC.69 Although the status of the scaffold protein
Par3 was not evaluated in these experiments, given
that it is a direct target for Rac1 during tight junction
assembly, it is possible that UV radiation also alters
the localization and/or adaptor activity of Par3. These
are important issues for future research.
Ichthyosis

Neonatal ichthyosis schlerosing cholangitis (NISCH)
is a very rare genetic disease in which affected individuals possess nonsense mutations in the CLDN1 gene,
resulting in complete absence of Claudin-1 protein.110
This syndrome results in cholangitis, skin abnormalities including sparse eyelashes and eyebrows, hypotrichosis and alopecia, as well as formation of a compact
and hyperkeratotic stratum corneum.110,111 Although
electron microscopic analyses of affected skin in some
patients have revealed apparently normal tight junctions, the status of the functional barrier has never
been examined. However, signiﬁcant phenotypic differences in several individuals carrying the same
mutation have been observed, suggesting the possibility that genetic modiﬁers may also contribute to the
severity of this disorder.112 Importantly, the role of
claudin-1 and/or the mechanisms activated to
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compensate for its loss in humans appear to differ
from those in mice, as inactivation of the Cldn1 gene
in the latter results in perinatal lethality with full penetrance.13 Also requiring further investigation are any
alterations that may occur in tight junction-associated
scaffold proteins and other components of these structures in the absence of claudin-1 in humans.
Ichthyosis vulgaris is a hereditary, autosomal semidominant skin disease mainly caused by loss-of-function mutations in the FLG gene, which encodes ﬁlaggrin.113 Although ﬁlaggrin is not directly involved in
tight junction assembly, it is an important contributor
to the stratum corneum inside-out barrier, and its
absence also affects the tight junction barrier. Both
ﬁlaggrin-deﬁcient humans and mice exhibit impaired
inside-out and outside-in barrier function, as evidenced, respectively, by increased transepidermal
water loss and small molecule penetration.114-117 Signiﬁcantly, loss of ﬁlaggrin in humans, but not in mice,
is accompanied by gene dosage-dependent decreases
in occludin and ZO-1 immunoreactivity in granular
keratinocytes,114 although additional studies are
needed to elucidate the molecular mechanisms
involved in these alterations.
Atopic dermatitis

Atopic dermatitis is a chronic inﬂammatory disease,
characterized by T-helper type 2 (Th2) inﬂammation
and epidermal barrier defects.118 Atopic dermatitis is
a relatively common disease, with a prevalence of
about 20% in children, and up to 10% in adults.118
Atopic dermatitis can arise as a consequence of multiple abnormalities, including FLG gene mutations,
which result in the absence of ﬁlaggrin or of biologically active ﬁlaggrin peptides, leading to disruptions in
the stratum corneum.119-122 Various single nucleotide
polymorphisms in the CLDN1 gene, which encodes
claudin-1 have been associated with some cohorts of
individuals affected by atopic dermatitis, as has
reduced expression of claudins -1 and -23.71 Experimentally, silencing and downregulation of claudin-1
in cultured human keratinocytes70,74 or genetic inactivation of Cldn1 in mice123 impairs both tight junctions
and the stratum corneum barrier. These observations,
together with the alterations in tight junctions consequent to ﬁlaggrin loss, are consistent with the possibility of reciprocal regulation of the tight junction and
stratum granulosum barriers.

Scaffold proteins associated with tight junctions
have received scarce attention in human atopic dermatitis or animal models of this disease. Decreased
ZO-1 expression has been reported in ﬁlaggrin-deﬁcient patients, and has been proposed as a contributor
to the epidermal barrier abnormalities in these individuals.114 Similarly, a recent study described
decreased and discontinuous ZO-1 immunoreactivity
in the affected areas of the epidermis in a canine
model of atopic dermatitis,124 suggesting that ZO-1
abnormalities may also be key contributors to the paracellular barrier defects present in individuals affected
by this disease. The complexity of the abnormalities
present in atopic dermatitis is increased by the role of
inﬂammation in affected skin, which also contributes
to the reduced stratum corneum barrier properties
and the increased paracellular permeability through
tight junctions.125
Infection

The skin is a target for infection by a variety of pathogens, including viruses, bacteria and fungi. The defensive ability of the skin against invading pathogens
results from the combined action of its physical barrier function, together with its immune antimicrobial
barrier capabilities.126 During infection, tight junctions and epidermal integrity can be affected through
a variety of mechanisms, including direct effects of the
invading pathogens and production of inﬂammatory
mediators in response to immune response activation.
Major viral agents that target the skin are the herpes
simplex and the human papilloma viruses. Herpes
simplex virus 1 (HSV-1) invades human hosts
through skin abrasions or mucosal surfaces, establishes life-long infections, which can lead to atopic
dermatitis and disseminated skin infections.127 Cellcell junctions provide an important barrier to viruses,
and their components can be used by these pathogens
as attachment receptors that mediate virus fusion with
the keratinocyte plasma membrane.128 HSV-1 does
not infect intact mouse epidermis or intact human
skin equivalents, but it can infect wounded human
skin equivalents.129 The formation of mature tight
junctions prevents HSV-1 invasion of keratinocyte
monolayers. Signiﬁcantly, disruption of tight junction
assembly due to Par3 deﬁciency in mouse keratinocyte
cultures results in increased HSV-1 infection upon
exposure to this virus,129 demonstrating that the
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ability of HSV-1 to invade stratiﬁed keratinocytes is
only maintained in conditions in which the functional
tight barrier is disrupted, thus facilitating virus access
to its attachment receptors.
Human papilloma virus (HPV) infections are key
risk factors for the development of cervical. as well as
head and neck, carcinomas. Various HPV proteins are
able to interact and interfere with the functions of
multiple cellular proteins. The high-risk HPV16 E6
protein targets PDZ-containing proteins involved in
cell polarity and intercellular junction formation. In
particular, E6 binds to Par3, altering its subcellular
localization, and interfering with tight junction assembly.130 Tight junction proteins also modulate cell proliferation and transformation, and it is possible that
the interference of the HPV E6 proteins with Par3
function and tight junction assembly contributes to
viral infection and replication, as well as to subsequent
cell transformation and tumourigenesis.
Aside from pathogenic viruses, major contributors to
bacterial skin infections are Staphylococcus aureus and
Streptococcus pyogenes,131 S aureus infections produce
abscess formation and worsening of atopic dermatitis
and other inﬂammatory conditions, and cause considerable morbidity and mortality.132,133 Multiple mechanisms are involved in S. aureus invasion, including
expression of an array of proteins that mediate bacterial
attachment to the keratinocyte plasma membrane and
extracellular matrix proteins, as well as production of
toxins that disrupt the epithelial barrier. Some toxins
also mediate proteolytic cleavage of desmoglein-1 and
desmosome disassembly.133 S. aureus also elicits inﬂammatory responses, which collectively contribute to
changes in the skin barrier. The changes in tight junctions associated with staphylococcal infections are complex and are dependent on the staphylococcal strain
analyzed. For example, early after S. aureus infection of
spontaneously immortalized HaCaT keratinocytes,
there is a disassembly of tight junctions, as evidenced
by marked decreases in ZO-1, claudin-1 and occludin
immunoreactivity at cell-cell contacts, without substantial alterations in the abundance of these proteins.134 In
these cells, localization of aPKC to tight junctions was
also severely affected, indicating the possibility that S.
aureus also targets, directly or indirectly, Par3 and/or
Par6. These changes were also accompanied by loss of
tight junction barrier functions associated with impeding paracellular ion transport.134 Similar decreases were
observed upon infection of porcine skin explants and
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in specimens of human skin diagnosed with generalized
S. aureus infection (impetigo contagiosa).134 In these
studies, no changes in adherens junctions or desmosomes were observed with the S. aureus strains used,
suggesting the possibility that exfoliative toxins from
some strains may preferentially target tight junction
components.
Host defense peptides (also termed antimicrobial peptides) are produced by keratinocytes and other cell types
in response to bacteria.135 Over 2,000 different human
host defense peptides are known. They function by killing pathogens and by modulating various biologic processes, including stimulation of chemotaxis, production
of cytokines and chemokines, regulation of epithelial cell
apoptosis, and suppression of pro-inﬂammatory
responses. Three host defense peptides with key roles in
cutaneous protection are cathelicidin, LL-37, b-defensins, and S100A7 (psoriasin).135 In intact skin, LL-37 is
barely detectable in keratinocytes, but it is strongly upregulated during infections or after injury.136 Signiﬁcantly,
LL-37 upregulates the expression of tight junction proteins, and increases tight junction barrier function by
reducing paracellular ﬂuxes in cultured keratinocytes.137
Mechanistically, LL-37 induces these effects through
activation of the Par3/Par6/aPKC pathway, as well as
through activation of Rac1 and glycogen synthase kinase
(GSK)-3.137 LL-37 functions synergistically with other
antibacterial peptides produced by nonpathogenic commensal bacteria that colonize healthy skin, and contributes to decreased S. aureus colonization in skin from
individuals with atopic dermatitis.138 An important area
for future research will be to determine if antibacterial
peptides from nonpathogenic commensals also synergize
with LL-37 in modulating the paracellular barrier function in the epidermis.
Integrin-linked kinase also plays key roles in the
susceptibility of the skin to S. aureus invasion.139 Speciﬁcally, staphylococcal penetration of skin explants
increased over 30-fold in specimens from mice with
epidermis-restricted inactivation of the Ilk gene. Given
that ILK-deﬁcient keratinocytes exhibit severely
impaired internalization of these bacteria, a major
component of the increased invasion observed is likely
associated with the loss of the paracellular permeability barrier in these animals.102 Signiﬁcantly, ILKdeﬁcient epidermis also exhibits upregulation of antimicrobial peptides, such as psoriasin,140 in agreement
with the known cutaneous responses to its increased
susceptibility to infection.
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Conclusions
Although the contribution of scaffold proteins to the
existence of functional tight junctions in the epidermis
has been ﬁrmly established for well over a decade,
many aspects of their biologic roles and their regulation remain unexplored. In particular, much remains
unknown about which and how scaffold proteins contribute to orchestrate such diverse events as differentiation, intercellular junction assembly, cytoskeletal
dynamics and control of paracellular solute movements. Future research will undoubtedly unearth
novel mechanisms and identify additional adaptor
proteins involved in the regulation of the epidermal
permeability barrier in health and in disease.
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